Novavax’s protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.

Gene therapy offered this 7-year-old freedom. The price: a grueling year

PHILADELPHIA — The meds Shelby Campbell needed for her rare blood disorder stopped working just after her sixth birthday. She lost her appetite and was

December 13, 2023

Canada approves AstraZeneca-Merck’s prostate cancer therapy

The trial evaluated Lynparza along with abiraterone versus placebo with abiraterone in male mCRPC patients. Credit: Image Point Fr / Shutterstock.com. AstraZeneca and Merck (MSD)

July 14, 2023

Nurse Shows Kids How to ‘Stop the Bleed’

About 8 years ago, California nurse Kate Carleton, RN, was watching a news special on an anniversary of the Sandy Hook elementary school shooting when

July 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.